• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Qa-1(b) 肽结合特异性分析以及CD94/NKG2A区分Qa-1-肽复合物的能力分析。

Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.

作者信息

Kraft J R, Vance R E, Pohl J, Martin A M, Raulet D H, Jensen P E

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

出版信息

J Exp Med. 2000 Sep 4;192(5):613-24. doi: 10.1084/jem.192.5.613.

DOI:10.1084/jem.192.5.613
PMID:10974028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2193274/
Abstract

The major histocompatibility complex class Ib protein, Qa-1(b), serves as a ligand for murine CD94/NKG2A natural killer (NK) cell inhibitory receptors. The Qa-1(b) peptide-binding site is predominantly occupied by a single nonameric peptide, Qa-1 determinant modifier (Qdm), derived from the leader sequence of H-2D and L molecules. Five anchor residues were identified in this study by measuring the peptide-binding affinities of substituted Qdm peptides in experiments with purified recombinant Qa-1(b). A candidate peptide-binding motif was determined by sequence analysis of peptides eluted from Qa-1 that had been folded in the presence of random peptide libraries or pools of Qdm derivatives randomized at specific anchor positions. The results indicate that Qa-1(b) can bind a diverse repertoire of peptides but that Qdm has an optimal primary structure for binding Qa-1(b). Flow cytometry experiments with Qa-1(b) tetramers and NK target cell lysis assays demonstrated that CD94/NKG2A discriminates between Qa-1(b) complexes containing peptides with substitutions at nonanchor positions P4, P5, or P8. Our findings suggest that it may be difficult for viruses to generate decoy peptides that mimic Qdm and raise the possibility that competitive replacement of Qdm with other peptides may provide a novel mechanism for activation of NK cells.

摘要

主要组织相容性复合体 Ib 类蛋白 Qa-1(b) 作为小鼠 CD94/NKG2A 自然杀伤(NK)细胞抑制性受体的配体。Qa-1(b) 肽结合位点主要被源自 H-2D 和 L 分子前导序列的单一九聚体肽 Qa-1 决定簇修饰物(Qdm)占据。在本研究中,通过在纯化的重组 Qa-1(b) 实验中测量取代的 Qdm 肽的肽结合亲和力,确定了五个锚定残基。通过对从在随机肽库或在特定锚定位置随机化的 Qdm 衍生物库存在下折叠的 Qa-1 洗脱的肽进行序列分析,确定了一个候选肽结合基序。结果表明,Qa-1(b) 可以结合多种肽,但 Qdm 具有结合 Qa-1(b) 的最佳一级结构。用 Qa-1(b) 四聚体进行的流式细胞术实验和 NK 靶细胞裂解试验表明,CD94/NKG2A 能够区分在非锚定位置 P4、P5 或 P8 有取代的肽的 Qa-1(b) 复合物。我们的研究结果表明,病毒可能难以产生模仿 Qdm 的诱饵肽,并增加了用其他肽竞争性取代 Qdm 可能提供激活 NK 细胞新机制的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/aa2ccc6ce8fc/JEM000842.f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/d7034250f101/JEM000842.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/c7eb4e164770/JEM000842.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/61d345641b29/JEM000842.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/88b665687fe9/JEM000842.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/b8ec41d439e5/JEM000842.f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/aa2ccc6ce8fc/JEM000842.f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/d7034250f101/JEM000842.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/c7eb4e164770/JEM000842.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/61d345641b29/JEM000842.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/88b665687fe9/JEM000842.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/b8ec41d439e5/JEM000842.f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc2/2193274/aa2ccc6ce8fc/JEM000842.f5.jpg

相似文献

1
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.Qa-1(b) 肽结合特异性分析以及CD94/NKG2A区分Qa-1-肽复合物的能力分析。
J Exp Med. 2000 Sep 4;192(5):613-24. doi: 10.1084/jem.192.5.613.
2
The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.非经典MHC I类分子Qa-1形成不稳定的肽复合物。
J Immunol. 2004 Feb 1;172(3):1661-9. doi: 10.4049/jimmunol.172.3.1661.
3
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.HLA-E肽结合特异性及CD94/NKG2识别所需结合肽中接触残基的分析。
J Immunol. 2003 Aug 1;171(3):1369-75. doi: 10.4049/jimmunol.171.3.1369.
4
Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.控制Qa1介导的靶细胞免受自然杀伤细胞裂解的分子因子的功能分析。
J Immunol. 2001 Feb 1;166(3):1601-10. doi: 10.4049/jimmunol.166.3.1601.
5
Structure of the murine CD94-NKG2A receptor in complex with Qa-1 presenting an MHC-I leader peptide.鼠 CD94-NKG2A 受体与呈递 MHC-I 前导肽的 Qa-1 复合物的结构。
FEBS J. 2024 Apr;291(7):1530-1544. doi: 10.1111/febs.17050. Epub 2024 Jan 10.
6
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.
7
The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.非经典MHC I类分子Qa-1(b)抑制细胞毒性T淋巴细胞的经典MHC I类限制性细胞毒性。
Int Immunol. 2001 Mar;13(3):321-7. doi: 10.1093/intimm/13.3.321.
8
Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo.Qdm/Qa-1b、Kb和Db在体内保护低表达II类细胞免受自然杀伤细胞介导的裂解的比较能力。
J Immunol. 2000 Dec 1;165(11):6142-7. doi: 10.4049/jimmunol.165.11.6142.
9
Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.Qa-1,一种在固有免疫和适应性免疫中发挥作用的非经典I类组织相容性分子。
Immunol Res. 2004;29(1-3):81-92. doi: 10.1385/IR:29:1-3:081.
10
Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.自然杀伤细胞通过CD94/NKG2受体识别HLA-E和Qa-1b介导的细胞内抗原加工途径的监测。
Microbes Infect. 2000 Apr;2(4):371-80. doi: 10.1016/s1286-4579(00)00330-0.

引用本文的文献

1
HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.HLA-E:结构研究揭示的免疫受体功能机制
Immunol Rev. 2025 Jan;329(1):e13434. doi: 10.1111/imr.13434.
2
Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response.流感病毒隐匿性 MHC-E 表位引发强烈的细胞毒性 T 细胞反应。
Nat Immunol. 2023 Nov;24(11):1933-1946. doi: 10.1038/s41590-023-01644-5. Epub 2023 Oct 12.
3
The complex HLA-E-nonapeptide in Behçet disease.贝赫切特病中的复杂 HLA-E 九肽。

本文引用的文献

1
Role of Qa-1(b)-binding receptors in the specificity of developing NK cells.Qa-1(b)结合受体在发育中的自然杀伤细胞特异性中的作用。
Eur J Immunol. 2000 Apr;30(4):1094-101. doi: 10.1002/(SICI)1521-4141(200004)30:4<1094::AID-IMMU1094>3.0.CO;2-9.
2
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.人巨细胞病毒gpUL40增强自然杀伤细胞抑制剂HLA-E的表面表达。
Science. 2000 Feb 11;287(5455):1031. doi: 10.1126/science.287.5455.1031.
3
Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens.
Front Immunol. 2023 Aug 10;14:1080047. doi: 10.3389/fimmu.2023.1080047. eCollection 2023.
4
Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors.NKG2A 和 PD-1 阻断联合改善放射抵抗肿瘤的放射治疗反应。
J Immunol. 2022 Aug 1;209(3):629-640. doi: 10.4049/jimmunol.2100044. Epub 2022 Jul 15.
5
Antigen presentation by MHC-E: a putative target for vaccination?MHC-E 递呈抗原:疫苗接种的潜在靶点?
Trends Immunol. 2022 May;43(5):355-365. doi: 10.1016/j.it.2022.03.002. Epub 2022 Mar 31.
6
Differential expression of inhibitory receptor NKG2A distinguishes disease-specific exhausted CD8 T cells.抑制性受体NKG2A的差异表达可区分疾病特异性耗竭的CD8 T细胞。
MedComm (2020). 2022 Jan 10;3(1):e111. doi: 10.1002/mco2.111. eCollection 2022 Mar.
7
Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function.源自潜伏周期蛋白的 Epstein-Barr 病毒肽改变了 NKG2A+NK 细胞的效应功能。
Sci Rep. 2020 Nov 17;10(1):19973. doi: 10.1038/s41598-020-76344-3.
8
Quantification of low affinity binding interactions between natural killer cell inhibitory receptors and targeting ligands with a self-induced back-action actuated nanopore electrophoresis (SANE) sensor.采用自感应反向作用驱动纳米孔电泳(SANE)传感器定量检测自然杀伤细胞抑制受体与靶向配体之间的低亲和力结合相互作用。
Nanotechnology. 2021 Jan 22;32(4):045501. doi: 10.1088/1361-6528/abbf26.
9
Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.肽与人、非人灵长类和小鼠 HLA-E 分子的结合揭示了独特的结合肽,但锚定残基惊人地保守。
J Immunol. 2020 Nov 15;205(10):2861-2872. doi: 10.4049/jimmunol.2000810. Epub 2020 Oct 5.
10
Natural Killer Cells: Tumor Surveillance and Signaling.自然杀伤细胞:肿瘤监测与信号传导
Cancers (Basel). 2020 Apr 11;12(4):952. doi: 10.3390/cancers12040952.
革兰氏阴性病原体感染后,由Ib类主要组织相容性复合体分子介导的分子模拟。
Nat Med. 2000 Feb;6(2):215-8. doi: 10.1038/72329.
4
Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand.与主要组织相容性复合体I类配体结合的凝集素样自然杀伤细胞受体的晶体结构。
Nature. 1999 Dec 9;402(6762):623-31. doi: 10.1038/45170.
5
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers.利用可溶性主要组织相容性复合体I类四聚体可视化抑制性Ly49受体特异性
Eur J Immunol. 2000 Jan;30(1):300-7. doi: 10.1002/1521-4141(200001)30:1<300::AID-IMMU300>3.0.CO;2-S.
6
Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.小鼠自然杀伤细胞上假定的激活受体CD94/NKG2C和CD94/NKG2E对Ib类分子Qa-1(b)的识别。
J Exp Med. 1999 Dec 20;190(12):1801-12. doi: 10.1084/jem.190.12.1801.
7
Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C.自然杀伤细胞抑制性受体Ly-49C的肽依赖性和选择性
Eur J Immunol. 1999 Sep;29(9):2748-58. doi: 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C.
8
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors.通过七种Ly49抑制性自然杀伤细胞受体对MHC I类结合进行直接评估。
Immunity. 1999 Jul;11(1):67-77. doi: 10.1016/s1074-7613(00)80082-5.
9
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
10
Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.前沿:功能性CD94/NKG2A抑制性受体在胎儿NK1.1+Ly-49-细胞上的表达:NK细胞发育过程中耐受的一种可能机制。
J Immunol. 1999 Jun 15;162(12):6976-80.